Sveriges mest populära poddar
Conversations in Drug Development
Hälsa och motionMedicin

Navigating the Future of EU Health Technology Assessments

29 min•16 oktober 2024

In this episode, host Dr Julie Warner is joined by experts from Decisive Consulting, Esther Nzenza, and Kevin Asher to discuss the upcoming joint clinical assessment (JCA) process set to begin in January 2025. The conversation covers the implications of the JCA for drug developers, particularly smaller companies, and emphasizes the importance of early planning and integrated evidence generation. Join us as we uncover the strategies and considerations essential for success in the ever-evolving world of health technology assessments.

Fler avsnitt av Conversations in Drug Development

Visa alla avsnitt av Conversations in Drug Development
Live Biotherapeutics: Navigating the Next Frontier in Drug Development
•32 min
UK Clinical Trial Regulation: What Sponsors Need to Know About UK CTR 2025
•26 min
How Will the EU Biotech Act Transform Biotechnology Regulation in Europe?
•30 min
Navigating the FDA Landscape: More Changes, and What's Next?
•27 min
At the forefront of innovation: Prof Alan Boyd reflects on the last 20 years in drug development
•40 min
Navigating the New FDA Landscape: Opportunities and Challenges Ahead
•36 min
From Lab to Launch – Avoiding the Pitfalls of Drug Development
•28 min
Crystal Ball Gazing: What Does the Future Hold for Regulatory Affairs in Drug Development for 2025
•33 min
How to Effectively De-Risk your IND Process
•53 min
Understanding EU Medical Device Regulations: Key Insights for Developers and Innovators
•24 min

Conversations in Drug Development med Boyds finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.